Study seeks new treatments for post-traumatic stress disorder in veterans, military personnel
A groundbreaking clinical trial launched October 16, 2023, will explore the promise of new drug treatments for military personnel and veterans suffering from post-traumatic stress disorder (PTSD). The multi-site trial is spearheaded by the U.S. Army Medical Materiel Development Activity (USAMMDA), part of the U.S. Army Medical Research and Development Command, and supported by a project team that includes representatives from the U.S. Air Force, Army, Navy, and Special Operations Command. (U.S. Army Courtesy Photo/Released)
